Consensus-based disease definitions for endocrine immune-related adverse events of immune checkpoint inhibitors

Immune checkpoint inhibitors (ICIs) are an important class of cancer treatment. Endocrine immune-related adverse events (E-irAEs) account for a significant proportion of irAEs in ICI-treated patients. Diagnosing E-irAEs accurately and timely can be challenging in the absence of clear categorization...

Szczegółowa specyfikacja

Opis bibliograficzny

Główni autorzy:	Cassandra Calabrese, Lavinia Spain, Katy Tsai, Elad Sharon, Michael Dougan, Pauline Funchain, Mark Yarchoan, Annette M Lim, Douglas B Johnson, Kerry L Reynolds, Allison Betof Warner, Ling Zhu, Irina Bancos, Tracey A Cho, Michel Khouri, Jennifer Mammen, Ana Luisa Perdigoto, Alina Markova, Ole-Petter R Hamnvik, Zoe Quandt, Alexa Meara, Michelle Ferreira, Meenal Kheterpal, Jon McDunn, Afreen Shariff, Trevor Angell, Yee-Ming M Cheung, Cherie Chiang, Emily J Gallagher, Renisha Jones, Huda Al-Bahadili, Susan Blackwell, Justine Herndon, Randol Kennedy, Melissa G Lechner, Laura Overton, Nirupa Sachithanandan
Format:	Artigo
Język:	Inglês
Wydane:	BMJ Publishing Group 2025-10-01
Seria:	Journal for ImmunoTherapy of Cancer
Dostęp online:	https://jitc.bmj.com/content/13/10/e011865.full
Etykiety:	Dodaj etykietę Nie ma etykietki, Dołącz pierwszą etykiete!